© Reuters. FILE PHOTO: GSK (GlaxoSmithKline) logo is seen in this illustration, August 10, 2022. REUTERS/Dado Ruvic/Illustration/File Photo
(Reuters) – British drugmaker GSK said on Wednesday it had raised 978 million pounds ($1.24 billion) from a discounted stake sale in Haleon, cutting its shareholding to 4.2% in the world’s largest standalone consumer healthcare firm.
GSK sold around 300 million shares in its spun-off unit at a price of 326 pence per share.
($1 = 0.7918 pounds)
Irregulars Quick Take Paid members get a quick summary of the stocks teased and our thoughts here. Join as a...
A global athletic retailer needed to scale its B2B resale program while maintaining strict channel control. Historically the retailer had...
What if the greatest investment in history wasn’t a stock… but a country? On July 4th, 2026, America turns 250...
This article was written byFollowI am an investment professional with over 7 years of experience spanning quant equities, asset management,...
Your neighbor pulls into the driveway with a new car. Your coworker shows up to the office with the latest...
Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.
